GlassScriptPhysician profile
Brian Kuhn
NPI 1841594496
$184,392.69
in general payments reported to CMS, 2019-2025
20 companies · $25.26 in 2025
The $25.26 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $20K · 2021: $22K · 2022: $31K · 2023: $17K · 2024: $12K · 2025: $25.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $4,681 · Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,050.00 |
| Travel and Lodging | $4,681.18 |
| Food and Beverage | $1,316.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $104,997.37 | 2019-2021 | |
| Nuvasive, INC. | $39,171.39 | 2019-2023 | Alif, Pulse |
| Shockwave Medical, INC | $13,299.00 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Globus Medical, INC. | $12,714.91 | 2023-2024 | Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System, Alif Instruments (Universal) |
| Penumbra, INC. | $3,996.93 | 2019-2021 | |
| Alphatec Spine, INC | $3,750.00 | 2023 | Solus Alif |
| Medtronic, INC. | $2,316.67 | 2022-2024 | Clydesdale Ptc Spinal System |
| W. L. Gore & Associates, INC. | $2,209.88 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, C3 Delivery System |
| Integrity Implants INC. | $1,000.00 | 2022 | |
| Cook Medical LLC | $250.91 | 2019 | |
| Novapproach Spine, LLC | $155.56 | 2023 | Onelif |
| Philips North America LLC | $141.56 | 2020 | |
| Abbott Laboratories | $113.45 | 2019 | |
| Boston Scientific Corporation | $94.73 | 2019-2020 | |
| Angiodynamics, INC. | $81.97 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $25.26 | 2025 | Artegraft Vascular Graft |
| Astrazeneca Pharmaceuticals LP | $24.15 | 2019 | |
| Bard Peripheral Vascular, INC. | $21.01 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.82 | 2019 | |
| Acell, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.